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Objective: Intraoperative pleural lavage cytology for lung cancer has not
been widely accepted. The prognostic significance of this procedure has
yet to be intensively analyzed because the reports published thus far have
involved small patient populations. We therefore performed a large pro-
spective trial of pleural lavage cytology to elucidate its importance.
Methods: Cytologic status of pleural lavage fluid before any manipulation
of the lung was examined in 1000 consecutive patients with non–small cell
lung cancer but no pleural effusion who underwent tumor resection.
Results: Forty-five (4.5%) of 1000 patients had positive cytologic find-
ings. Positive cytologic findings were observed more frequently in patients
with adenocarcinoma, advanced stage, higher involvement of lymph
nodes, pleural involvement of the tumor, lymphatic permeation, vascular
invasion, high level of serum carcinoembryonic antigen, and male sex.
The survival rate for 5 years was 28% in patients with positive findings
and 67% in patients with negative findings (P  .0001). Among 587
patients with stage I disease, 13 (2.2%) had positive findings, and their
5-year survival was 43%, which was significantly poor compared with that of
patients with negative findings (81%, P  .0009). Multivariable analysis demon-
strated that pleural lavage cytology was an independent prognostic determinant (P
 .0290). Regarding the recurrence pattern in patients with positive findings, distant
metastases (19/45 [42.2%]) were observed more frequently rather than local recur-
rences (19/45 [22.2%]).
Conclusions: Cytologic status of pleural lavage fluid immediately after thoracot-
omy, an independent significant prognostic factor, constitutes valuable information
to detect patients at a high risk of recurrence. Therefore cytology should be
performed at the time of curative resection for non–small cell lung cancer.
In general, the presence of malignant cells in pleural effusion of patientswith lung cancer is indicative of advanced disease and poor prognosis.However, despite the lack of malignant effusion or dissemination macro-scopically, there are instances in which malignant cells might be present inthe pleural cavity.1-6 In previous reports the rate of positive results ofpleural lavage cytology before lung manipulation for non–small cell lung
cancer was 4% to 14%.1-3,5,7,8 The patients with positive lavage cytologic findings,
which might indicate an initial stage of carcinomatous pleuritis, have a poor survival
rate because a small amount of malignant pleural effusion or a few minute pleural
dissemination nodules are probably overlooked at thoracotomy. Cytologic findings
of positive lavage fluid without effusion might be ascribed to exfoliation from
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tumors at the pleural surface, thereby representing localized
disease, or it might correspond to disseminated disease,
implying much more aggressive tumor biology. Currently,
cytologic examination of pleural lavage fluid is not rou-
tinely performed before resection for lung cancer. The role
of this procedure has yet to be intensively investigated
because the reports published thus far dealt with small
patient populations. The present study, which is a large
prospective trial built on our previously reported experience
with pleural lavage fluid in patients undergoing resection for
lung cancer1 and followed for long-term outcome, was
undertaken to analyze the survival and the pattern of recur-
rence and to evaluate the independent prognostic signifi-
cance of pleural lavage fluid cytology.
Material and Methods
From January 1987 to December 2001, cytologic status of pleural
lavage fluid was examined before any manipulation or resection of
the lung in 1000 consecutive patients who had no pleural effusion
or diffuse adhesions and who underwent resections for primary
non–small cell lung cancer. Informed consent was sought from
each patient in regard to participation in this research.
Only when there was no macroscopic pleural effusion was the
patient included in this study. Patients with macroscopic pleural
effusion that could be collected with a syringe were excluded from
this study. Patients who had been subjected to preoperative che-
motherapy or radiotherapy were excluded. Preoperative evaluation
included a detailed history and physical examination, biochemical
profile, chest radiographic examination, bronchoscopy, and com-
puted tomography of the chest, brain, and upper portion of the
abdomen. Because there is some fear that preoperative transtho-
racic needle aspiration biopsy might cause the mechanical exfoli-
ation of cancer cells into the pleural cavity,9 we have avoided
transthoracic biopsy from the beginning of this study. Seventy-four
patients with malignant effusion who underwent resection for
primary tumor during the same period but who were excluded
from this study served as control subjects for comparison of
survival. They had the same clinical background as patients with
positive pleural lavage cytologic findings. Immediately after tho-
racotomy, the pleural cavity was carefully washed with 100 mL of
physiologic saline solution before any further manipulation of the
pulmonary parenchyma. The surgeon avoided touching the pleural
surface to obtain only desquamated cells. The fluid was then put
into a glass bottle with heparin and was centrifuged at 1500 rpm
for 5 minutes. The obtained sedimented material was stained with
the Giemsa and Papanicolaou methods. The results of the cytologic
examination were divided into 2 categories: negative and positive.
Papanicolaou classes I to III were regarded as negative, and classes
IV to V were regarded as positive. Pathologic staging was deter-
mined according to the international staging system.10 Intraoper-
ative staging was done by means of dissecting intrapulmonary,
hilar, and mediastinal lymph nodes, and careful postoperative
examination was carried out by pathologists. The histologic type of
the tumor was determined by applying the World Health Organi-
zation classification. The outcomes of histopathologic examination
regarding the status of lymph node metastasis, pleural involvement
of the tumor, lymphatic permeation by the tumor, and vascular
involvement of the tumor were abbreviated as N, P, Ly, and V
factors, respectively. These factors were defined as follows: N0, no
lymph node metastasis; N1, metastasis in hilar nodes; N2, metas-
tasis in ipsilateral mediastinal nodes; P(), tumor has invaded the
visceral pleura; P(), tumor has not invaded the visceral pleura;
Ly(), positive lymphatic permeation; Ly(), negative lymphatic
permeation; V(), positive vascular involvement; and V(), neg-
ative vascular involvement. The normal limit for serum carcino-
embryonic antigen (CEA), as assessed by means of immunoenzy-
mometric assay, was 5 ng/mL. From the representative sections
stained with hematoxylin and eosin or elastica van Gieson, the
presence of tumor cells, including emboli, in endothelial-lined
channels of lymphatic and vascular vessels was determined by
means of identification of intratumoral lymphatic permeation and
vascular involvement, respectively. The Mann-Whitney U test was
carried out to investigate the associations between cytologic results
of pleural lavage fluid and clinicopathologic factors. Survival was
calculated by using the Kaplan-Meier method, and differences in
survival were determined by means of log-rank analysis. A mul-
tivariable analysis of several prognostic factors was carried out by
using the Cox proportional hazards regression model. Zero time
was the date of pulmonary resection, and the terminal event was
death attributable to cancer, noncancer, or unknown causes.
Results
Among 1000 patients with non–small cell lung cancer in
whom pleural lavage cytologic status was examined, 45
(4.5%) had positive findings. The cytologic outcomes of
pleural lavage according to histologic type, pathologic
stage, status of lymph node metastasis, pleural involvement
of the tumor, lymphatic permeation by the tumor, vascular
involvement by the tumor, preoperative value of serum
CEA, sex, and age are shown in Table 1. Positive cytologic
findings were observed much more frequently in patients
with adenocarcinoma (6.9% [43/622]). Few patients with
squamous cell carcinoma had positive cytologic findings
(0.6% [2/339]), and neither patients with large cell carci-
noma nor those with adenosquamous carcinoma had posi-
tive results. Even in pathologic stage I disease, 13 (2.2%) of
587 patients had findings positive for malignancy. Malig-
nant cells were detected in the pleural lavage fluid of 6
(3.5%) of 173 patients with stage II disease and 26 (10.8%)
of 240 patients with stage III disease. Positive findings were
seen more frequently in advanced stages. Malignant cells
were detected in the pleural lavage fluid of 20 (2.2%) of 658
patients without nodal involvement, 8 (4.7%) of 171 pa-
tients with N1 disease, and 17 (9.9%) of 171 patients with
N2 disease. Positive findings were more common in cases of
higher involvement of lymph nodes. All patients were his-
topathologically examined for pleural invasion, lymphatic
permeation, and vascular involvement. The rates of positive
cytologic findings in patients with pleural, lymphatic, and
vascular involvement were 16.7% (30/180), 10.3% (33/
321), and 7.5% (32/429), respectively, although in patients
without these factors, the rates were 1.8% (15/820), 1.8%
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(12/679), and 2.3% (13/571), respectively. The frequency of
positive cytologic findings in patients with a higher value of
preoperative serum CEA was 6.8% (26/381), whereas in
patients with CEA values within normal limits, it was 3.1%
(19/619). There were 619 men and 381 women, with a mean
age of 64.2 years (range, 32-85 years). Cancer cells were
found in the pleural lavage fluid of 25 (3.6%) of 697 male
patients and in that of 20 (6.6%) of 303 female patients. The
findings of cytologic examination were not influenced by
age. Overall follow-up ranged from 12 to 192 months, with
a median (for patients still alive) of 62 months. The 3- and
5-year survival rates were 46% and 28%, respectively, in
patients with positive findings of pleural lavage and 75%
and 67% in patients with negative findings (Figure 1). The
survival rate was significantly poorer in patients with pos-
itive findings than in those with negative findings (P 
.0001). Also, the survival rates for 3 and 5 years were 26%
and 16%, respectively, in patients with macroscopic malig-
nant effusion. These data suggested malignant effusion
could contribute to a worse prognosis compared with pos-
itive lavage cytologic findings (P  .0510). The patients
with pathologic stage I disease are generally assumed to
have been cured after complete resection of the tumor
because lymph nodes were not involved. However, we
found that a considerable number of patients having positive
cytologic findings had recurrences despite being given a
diagnosis of stage I disease. The 5-year survival rates of
patients with stage I disease with negative and positive
cytologic findings were 81% and 43%, respectively (Figure
2), indicating that positive cytologic findings were associ-
ated with a significantly worse prognosis than negative
cytologic findings, even in patients with stage I disease (P
.0009). The survival outcomes should be analyzed not only
by means of univariate analysis but also by means of mul-
tivariable analysis for the prognostic significance of pleural
lavage cytology to be strongly emphasized. Multivariable
Cox analysis of patients subjected to lavage cytologic ex-
amination demonstrated that pleural lavage cytology (P 
.0290), as well as sex (P  .0291), age (P  .0131), CEA
level (P  .0017) pathologic stage (P  .0001), lymphatic
permeation (P  .0101), and vascular involvement (P 
.0237), were independent and significant prognostic deter-
minants (Table 2). Of 45 patients with positive findings of
pleural lavage fluid, 29 (64.4%) have already had recur-
rences (Table 3). Distant metastases (65.5% [19/29]) were
observed more frequently than local recurrences, including
pleural recurrences (34.5% [10/29]). Even in patients with
stage I disease, 6 (46.2%) of 13 patients with positive
findings had distant metastases, and 2 (15.4%) had pleural
recurrences.
Discussion
The real question investigated in this study was whether
patients who otherwise appear to have resectable tumors
would have a worse prognosis if the pleural lavage cyto-
logic findings were positive. When patients with stage I
TABLE 1. Cytologic results of pleural lavage fluid according to clinical and pathologic characteristics
Pleural lavage cytology
Total (n  1000) P valuePositive (n  45) Negative (n  955)
Adenocarcinoma 43 (6.9%) 579 622 .0002
Squamous cell carcinoma 2 (0.6%) 337 339
Large cell carcinoma 0 (0) 24 24
Adenosquamous carcinoma 0 (0) 15 15
P-stage I 13 (2.2%) 574 587 .0001
P-stage II 6 (3.5%) 167 173
P-stage III 26 (10.8%) 214 240
N0 20 (3.3%) 638 658 .0032
N1 8 (4.7%) 163 171
N2 17 (9.9%) 154 171
P() 15 (1.8%) 805 820 .0001
P() 30 (16.7%) 150 180
Ly() 12 (1.8%) 667 679 .0001
Ly() 33 (10.3%) 288 321
V() 13 (2.3%) 558 571 .0009
V() 32 (7.5%) 397 429
CEA () 19 (3.1%) 600 619 .0005
CEA () 26 (6.8%) 355 381
Male 25 (3.6%) 672 697 .0928
Female 20 (6.6%) 283 303
Age  64 y 20 (4.4%) 430 450 .4598
Age  65 y 25 (4.5%) 525 550
P-stage, Pathologic stage; N, lymph node metastasis; P, pleural involvement; Ly, lymphatic permeation; V, vascular involvement.
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disease had positive cytologic findings, they showed a sig-
nificantly poor prognosis, and their 5-year survival was less
than 50% in contrast to more than 80% for those with
negative cytologic findings (Figure 2). In previous reports
the prognostic importance of pleural lavage cytology was
noted, but its independence in statistics is not known as yet.
In this study multivariable analysis demonstrated pleural
lavage cytology, as well as sex, age, preoperative serum
CEA value, pathologic stage, lymphatic permeation, and
vascular involvement are independent prognostic determi-
nants. Therefore the status of pleural lavage cytology is
considered to have a strong effect on survival.
In our previous study the survival rate of patients with
positive lavage findings was as poor as that of patients with
macroscopic malignant effusion.1 However, in the present
study patients with positive findings tended to have a better
Figure 1. Cumulative survival curves of patients according to cytologic status of pleural lavage fluid. There were
74 patients with malignant effusion undergoing resection of the primary tumor during the same period, but they
were excluded from this study. The survival rate of patients with positive cytologic findings was significantly
worse than that of patients with negative cytologist findings (P < .0001). In addition, patients with positive
cytologic findings had a better (not significant) prognosis than those with malignant effusion (P  .0510).
Figure 2. Cumulative survival curves of patients with pathologic stage I disease according to cytologic status of
pleural lavage fluid. The survival rate of patients with positive cytologic findings was significantly worse than that
of patients with negative cytologic findings (P  .0009).
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prognosis than those with malignant effusion. This discrep-
ancy might be due to the difference in the number of
patients evaluated and the period of follow-up. In fact, it
was of interest to speculate that patients without malignant
effusion who showed positive findings of lavage cytology
might have a relatively small number of cancer cells in the
pleural cavity compared with those with malignant effusion.
In other words, it could be concluded that positive lavage
cytologic findings are indicative of subclinical pleural dis-
semination or a stage previous to pleural dissemination.
In this study the link between positive findings on pleural
lavage cytology and the histologic type of the tumor should
be emphasized. To our surprise, 43 (95.6%) of 45 patients
with positive cytologic findings were given a diagnosis of
adenocarcinoma. In addition, 43 (6.9%) of 622 patients with
adenocarcinoma had positive cytologic findings. The pres-
ence of subclinical pleural dissemination in a percentage of
just about 1 to 15 patients given a diagnosis of adenocarci-
noma, even without pleural effusion, is worthy of note.
Therefore in patients with lung cancer, especially adenocar-
cinoma, cytologic examination of pleural lavage fluid
should be performed routinely before beginning curative
resections and when determining the final stage. One of the
most interesting issues refers to how recurrences occur in
patients with just positive pleural lavage cytologic findings,
particularly in those who were otherwise given a diagnosis
of stage I disease. Our data revealed that distant metastasis
developed more frequently than local recurrence, including
pleural effusion, only among patients with stage I disease
and patients with positive lavage findings. Positive cyto-
logic findings of pleural lavage fluid might suggest aggres-
sive biology of the cancer itself because Buhr and col-
leagues4 reported this indicated tumor spread not only in the
chest but in the whole body. At present, the pleural lavage
procedure is not commonly performed during the staging or
resection of tumors in patients with lung cancer. This study
describes the significant independent value of the presence
or absence of cancer cells in the pleural lavage fluid of
patients undergoing staging or resection for non–small cell
lung cancer, particularly adenocarcinoma.
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TABLE 3. Recurrence pattern in patients with positive
pleural lavage cytologic findings (n  45)
Stage I Stage II Stage III Total
No. of patients 13 6 26 45
No recurrences 5 4 7 16
With recurrence 8 2 19 29
Local (pleural cavity) 2 (2) 1 (1) 7 (5) 10 (8)
Distant 6 1 12 19
TABLE 2. Multivariable analysis of prognostic factors (n  1000)
Factors Unfavorable Favorable Risk ratio 95% CI P value
Sex Male Female 1.550 1.171–2.052 .0022
Age  65  64 1.330 1.062–1.665 .0131
CEA Positive Negative 1.431 1.143–1.791 .0017
Histology Non-AD AD 1.236 0.970–1.574 .0862
Pathologic stage II  III I 3.007 2.346–3.854  .0001
Lymphatic permeation Positive Negative 1.377 1.079–1.759 .0101
Vascular involvement Positive Negative 1.307 1.171–2.052 .0237
Lavage cytology Positive Negative 1.634 1.051–2.539 .0290
AD, Adenocarcinoma.
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